FERRARA PIETRO

Ruggeri, L., Lipani, R., Cassataro, G., Paterno, V., Sinatra, N., Carollo, C., et al. (2026). Obesity, body adiposity, and intracranial aneurysms: A narrative review of clinical evidence beyond body mass index. OBESITY RESEARCH & CLINICAL PRACTICE, 20(3), 176-184 [10.1016/j.orcp.2026.05.005]. Detail

Antonazzo, I., Losa, L., Rozza, D., Pennini, I., Costacurta, M., Ulgharaita, I., et al. (2026). Appropriate use of Doxy-PEP and inappropriate antibiotic self-medication for STI management: insights from a LGBTQIA+ survey in Italy. BMC PUBLIC HEALTH, 26(1) [10.1186/s12889-026-27274-8]. Detail

Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Detail

Zamagni, G., Armocida, B., Castelpietra, G., Conti, S., Cortesi, P., Ferrara, P., et al. (2026). Il carico di malattia in Italia, dal 1990 al 2023: un’analisi regionale dal Global Burden of Disease Study 2023. EPIDEMIOLOGIA E PREVENZIONE, 50(1), 67-77 [10.19191/EP26.1.A991.020]. Detail

Ferrara, P. (2026). DoxyPEP is not just doxycycline: preventing informal antibiotic use through counselling, linkage to care, and stewardship. INFECTIOUS DISEASES NOW, 56(5) [10.1016/j.idnow.2026.105321]. Detail